Hanna Källmark
1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
Källmark, Hanna LU
; Gullstrand, Birgitta
LU
; Kahn, Fredrik
LU
; Grenmyr, Elsa
LU
; Kahn, Robin
LU
; Einarsson, Jon T.
LU
; Bengtsson, Anders A.
LU
and Kapetanovic, Meliha C.
LU
(2026)
In Rheumatology
65(1).
- Contribution to journal › Article
- 2025
-
Mark
Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity : Results of a Randomized Controlled Trial
(2025) In Clinical Infectious Diseases
- Contribution to journal › Article
- 2024
-
Mark
Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
Källmark, Hanna LU
; Bergström, Tomas
; Nagel, Johanna
LU
; Gullstrand, Birgitta
LU
; Einarsson, Jon T.
LU
; Bengtsson, Anders A.
LU
and Kapetanovic, Meliha C.
LU
(2024)
In Rheumatology (United Kingdom)
63(7).
p.2024-2033
- Contribution to journal › Article
- 2021
-
Mark
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study
Källmark, Hanna LU
; Einarsson, Jon T.
LU
; Nilsson, Jan Åke
LU
; Olofsson, Tor
LU
; Saxne, Tore
LU
; Geborek, Pierre
LU
and C. Kapetanovic, Meliha
LU
(2021)
In Arthritis and Rheumatology
73(7).
p.1135-1144
- Contribution to journal › Article